PerpEquities

Merck & Co., Inc. (MRK) balance sheet

NYSE · Healthcare · Drug Manufacturers - General · 74,000 employees · CEO Robert Davis

Price
$149.52 +2.18%
Market cap
$369B
Enterprise value
$416B
Last report
Q3 '26 filed 2026-09-30
Next report
2027-02-02 EPS est. $1.79

At the end of Q2 '26 Merck & Co., Inc. (MRK) held $7.14B in cash and short-term investments against $53.9B of debt incl. leases. Total assets $130B, total liabilities $87.8B, shareholders' equity $41.9B.

Balance sheet

Balance sheetTrendQ3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Assets
Cash & equivalents$8.61B$6.84B$5.58B$11.3B$14.6B$13.2B$8.63B$8.01B$18.2B$14.6B$5.33B$6.85B
Short-term investments$168M$252M$40M$50M$0$447M$599M$615M$45M$0$375M$292M
Receivables$10.4B$10.3B$11.4B$11.6B$11.4B$10.3B$10.8B$11.8B$12.1B$12.7B$12.2B$12.6B
Inventory$6.13B$6.36B$6.51B$6.47B$6.24B$6.11B$6.2B$6.6B$6.44B$6.66B$6.48B$6.21B
Other current assets$6.66B$8.37B$7.95B$8.74B$8.14B$8.71B$9.29B$10B$10.8B$9.49B$10.6B$10.8B
Current assets$32B$32.2B$31.4B$38.2B$40.4B$38.8B$35.5B$37.1B$47.6B$43.5B$35B$36.7B
Property, plant & equipment (net)$22.5B$23.1B$23B$23.2B$23.4B$23.8B$24.8B$25.2B$25.6B$26.8B$25.4B$25.7B
Long-term investments$1.31B$252M$280M$357M$575M$463M$616M$774M$1.12B$2.24B$1.11B$1.22B
Goodwill$21.2B$21.2B$21.2B$21.2B$21.7B$21.7B$21.7B$21.6B$21.6B$21.6B$21.6B$21.6B
Intangible assets$19.2B$18B$17.6B$17B$17B$16.4B$15.8B$15.2B$15.3B$26.7B$25.7B$25B
Other non-current assets$10.6B$12B$12.3B$12.7B$14.4B$16B$16.8B$17.7B$18.3B$16B$19.8B$19.6B
Non-current assets$74.8B$74.5B$74.4B$74.4B$77.2B$78.3B$79.6B$80.5B$82B$93.4B$93.7B$93.1B
Total assets$107B$107B$106B$113B$118B$117B$115B$118B$130B$137B$129B$130B
Liabilities
Accounts payable$3.51B$3.92B$3.51B$3.52B$3.59B$4.08B$3.78B$3.89B$4.15B$4.4B$3.86B$3.83B
Accrued expenses$14.8B$15.8B$14.1B$14.7B$16.5B$15.7B$12.8B$14.5B$16.2B$85M$14.5B$0
Short-term debt$887M$1.37B$3.08B$3.07B$3.15B$2.65B$1.36B$1.43B$1.41B$2.88B$2.44B$2.83B
Taxes payable$1.98B$2.65B$2.4B$2.78B$4.33B$3.91B$5.18B$4.16B$4.85B$0$3.95B$4.22B
Other current liabilities$0-$285M$0$0$0-$282M$0$0$0$14.1B$0$18.9B
Current liabilities$23.1B$25.7B$25.1B$26.1B$29.6B$28.4B$25.2B$26B$28.6B$28.3B$26.9B$27.7B
Long-term debt$34B$33.7B$31.1B$34.7B$35B$34.5B$33.5B$34B$40B$46.8B$46.7B$51.1B
Lease obligations (non-current)$0$928M$0$0$0$877M$0$0$0$901M$0$0
Deferred tax liabilities$1.02B$871M$922M$876M$864M$1.39B$1.41B$1.43B$1.38B$1.44B$1.49B$1.43B
Other non-current liabilities$7.34B$7.86B$8.26B$7.33B$7.54B$5.59B$6.66B$7.03B$7.66B$6.79B$7.64B$7.57B
Non-current liabilities$42.3B$43.3B$40.3B$42.9B$43.4B$42.3B$41.5B$42.4B$49B$55.9B$55.8B$60.1B
Total liabilities$65.4B$69B$65.4B$69B$73B$70.7B$66.7B$68.5B$77.6B$84.2B$82.8B$87.8B
Equity
Common stock & paid-in capital$1.79B$1.79B$1.79B$1.79B$1.79B$1.79B$1.79B$1.79B$1.79B$1.79B$1.79B$1.79B
Retained earnings$57.1B$53.9B$56.7B$60.2B$61.4B$63.1B$66.1B$68.5B$72.2B$73.1B$66.7B$63.3B
Accumulated other comprehensive income-$4.92B-$5.16B-$5.27B-$5.36B-$5.37B-$4.95B-$4.97B-$5.42B-$5.2B-$4.29B-$4.06B-$3.94B
Shareholders' equity$41.2B$37.6B$40.4B$43.6B$44.5B$46.3B$48.3B$49B$51.9B$52.6B$45.9B$41.9B
Debt
Total debt (incl. leases)$34.9B$36.3B$34.2B$37.8B$38.1B$38.3B$34.8B$35.4B$41.4B$50.5B$49.1B$53.9B
Net debt (debt - cash)$26.3B$29.4B$28.6B$26.5B$23.5B$25B$26.2B$27.4B$23.2B$36B$43.8B$47.1B

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30

Data as of 2026-11-01